Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.17 USD
Change Today -0.11 / -0.77%
Volume 5.6K
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Timothy P. Noyes

Chief Executive Officer, President and Director,Proteon Therapeutics Inc
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Timothy P. Noyes has been the President and Chief Executive Officer of Proteon Therapeutics Inc since April 2006. Mr. Noyes serves as the President of Iconix Pharmaceuticals Inc. He served as the Chief Operating Officer of Trine Pharmaceuticals Inc. (formerly, Essential Therapeutics Inc.) since August 2002. He has more than 15 years of industry experience. Mr. Noyes joined Trine in August 2002. He served as President of Genzyme Corporation, Genzyme's Renal and GelTex ...

Read Full Background

Corporate Headquarters*

200 West Street
Waltham, Massachusetts 02451

United States

Phone: 781-890-0102
Fax: 781-487-6729

Board Members Memberships*

Chief Executive Officer, President and Director


Harvard Business School
Harvard College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$408,158

Stock Options*

All Other Compensation$4,670
Exercisable Options385,966
Unexercisable Options78,818
Total Number of Options464,784

Total Compensation*

Total Annual Cash Compensation$542,976
Total Short Term Compensation$408,158
Other Long Term Compensation$4,670
Total Calculated Compensation$1,521,427
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRTO:US $14.17 USD -0.11


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROTEON THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at